Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice

ανά Melariri, Paula, Kalombo, Lonji, Nkuna, Patric, Dube, Admire, Hayeshi, Rose, Ogutu, Benhards, Gibhard, Liezl, deKock, Carmen, Smith, Peter, Wiesner, Lubbe, Swai, Hulda
Τόπος έκδοσης Int J Nanomedicine (2015)

Spray-Dried, Nanoencapsulated, Multi-Drug Anti-Tuberculosis Therapy Aimed at Once Weekly Administration for the Duration of Treatment

ανά Kalombo, Lonji, Lemmer, Yolandy, Semete-Makokotlela, Boitumelo, Ramalapa, Bathabile, Nkuna, Patric, Booysen, Laetitia L.L.I.J., Naidoo, Saloshnee, Hayeshi, Rose, Verschoor, Jan A., Swai, Hulda S.
Τόπος έκδοσης Nanomaterials (Basel) (2019)